205 related articles for article (PubMed ID: 23252395)
21. Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.
Schultz RG; Gryaznov SM
Nucleic Acids Res; 1996 Aug; 24(15):2966-73. PubMed ID: 8760881
[TBL] [Abstract][Full Text] [Related]
22. Promotion of triplex formation by N3'-->P5' phosphoramidate modification: thermodynamic and kinetic studies.
Torigoe H
Nucleic Acids Res Suppl; 2001; (1):57-8. PubMed ID: 12836262
[TBL] [Abstract][Full Text] [Related]
23. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
Herbert BS; Pongracz K; Shay JW; Gryaznov SM
Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
[TBL] [Abstract][Full Text] [Related]
24. Synergistic stabilization of triplex by combination of comb-type cationic copolymer and oligo-N3'-->P5' phosphoramidates.
Torigoe H; Akaike T; Maruyama A
Nucleic Acids Res Suppl; 2001; (1):195-6. PubMed ID: 12836331
[TBL] [Abstract][Full Text] [Related]
25. Reevaluation of stereoelectronic contributions to the conformational properties of the phosphodiester and N3'-phosphoramidate moieties of nucleic acids.
Banavali NK; MacKerell AD
J Am Chem Soc; 2001 Jul; 123(28):6747-55. PubMed ID: 11448177
[TBL] [Abstract][Full Text] [Related]
26. NMR solution structure of the N3' --> P5' phosphoramidate duplex d(CGCGAATTCGCG)2 by the iterative relaxation matrix approach.
Ding D; Gryaznov SM; Wilson WD
Biochemistry; 1998 Sep; 37(35):12082-93. PubMed ID: 9724520
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates.
Chen JK; Schultz RG; Lloyd DH; Gryaznov SM
Nucleic Acids Res; 1995 Jul; 23(14):2661-8. PubMed ID: 7651827
[TBL] [Abstract][Full Text] [Related]
28. Enhanced nonenzymatic RNA copying with in-situ activation of short oligonucleotides.
Ding D; Zhang SJ; Szostak JW
Nucleic Acids Res; 2023 Jul; 51(13):6528-6539. PubMed ID: 37247941
[TBL] [Abstract][Full Text] [Related]
29. Thermodynamic and kinetic effects of N3'-->P5' phosphoramidate modification on pyrimidine motif triplex DNA formation.
Torigoe H
Biochemistry; 2001 Jan; 40(4):1063-9. PubMed ID: 11170429
[TBL] [Abstract][Full Text] [Related]
30. New Oligonucleotide 2'-O-Alkyl N3'→P5' (Thio)-Phosphoramidates as Potent Antisense Agents: Physicochemical Properties and Biological Activity.
Martínez-Montero S; Rajwanshi VK; Pandey RK; De Costa NTS; Hong J; Beigelman L; Gryaznov SM; Pourshahian S
Nucleic Acid Ther; 2023 Oct; 33(5):319-328. PubMed ID: 37638793
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and purification of oligonucleotide N3'-->P5' phosphoramidates and their phosphodiester and phosphorothioate chimeras.
Fearon KL; Nelson JS
Curr Protoc Nucleic Acid Chem; 2001 May; Chapter 4():Unit 4.7. PubMed ID: 18428854
[TBL] [Abstract][Full Text] [Related]
32. Activated ribonucleotides undergo a sugar pucker switch upon binding to a single-stranded RNA template.
Zhang N; Zhang S; Szostak JW
J Am Chem Soc; 2012 Feb; 134(8):3691-4. PubMed ID: 22296305
[TBL] [Abstract][Full Text] [Related]
33. Synthetic oligonucleotides as RNA mimetics: 2'-modified Rnas and N3'-->P5' phosphoramidates.
Egli M; Gryaznov SM
Cell Mol Life Sci; 2000 Sep; 57(10):1440-56. PubMed ID: 11078022
[TBL] [Abstract][Full Text] [Related]
34. Structural interpretation of the effects of threo-nucleotides on nonenzymatic template-directed polymerization.
Zhang W; Kim SC; Tam CP; Lelyveld VS; Bala S; Chaput JC; Szostak JW
Nucleic Acids Res; 2021 Jan; 49(2):646-656. PubMed ID: 33347562
[TBL] [Abstract][Full Text] [Related]
35. A remarkable stabilization of complexes formed by 2,6-diaminopurine oligonucleotide N3'-->P5' phophoramidates.
Matray T; Gamsey S; Pongracz K; Gryaznov S
Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):1553-67. PubMed ID: 11200259
[TBL] [Abstract][Full Text] [Related]
36. Loop-loop interaction of HIV-1 TAR RNA with N3'-->P5' deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcription.
Darfeuille F; Arzumanov A; Gryaznov S; Gait MJ; Di Primo C; Toulmé JJ
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9709-14. PubMed ID: 12105271
[TBL] [Abstract][Full Text] [Related]
37. Zwitterionic oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and properties.
Mignet N; Gryaznov SM
Nucleic Acids Res; 1998 Jan; 26(2):431-8. PubMed ID: 9421496
[TBL] [Abstract][Full Text] [Related]
38. Template-Directed Nonenzymatic Primer Extension Using 2-Methylimidazole-Activated Morpholino Derivatives of Guanosine and Cytidine.
Zhang W; Pal A; Ricardo A; Szostak JW
J Am Chem Soc; 2019 Jul; 141(30):12159-12166. PubMed ID: 31298852
[TBL] [Abstract][Full Text] [Related]
39. Phototriggered DNA phosphoramidate ligation in a tandem 5'-amine deprotection/3'-imidazole activated phosphate coupling reaction.
Cape JL; Edson JB; Spencer LP; DeClue MS; Ziock HJ; Maurer S; Rasmussen S; Monnard PA; Boncella JM
Bioconjug Chem; 2012 Oct; 23(10):2014-9. PubMed ID: 22985338
[TBL] [Abstract][Full Text] [Related]
40. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
